Mark Murcko - 08 Sep 2022 Form 4 Insider Report for Relay Therapeutics, Inc. (RLAY)

Role
Director
Signature
/s/ Brian Adams, as attorney-in-fact
Issuer symbol
RLAY
Transactions as of
08 Sep 2022
Net transactions value
-$748,750
Form type
4
Filing time
08 Sep 2022, 20:31:27 UTC
Previous filing
27 May 2022
Next filing
01 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RLAY Common Stock Sale $748,750 -25,000 -2.4% $29.95 996,952 08 Sep 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2022.